Ticker > Company >

Remedium Lifecare share price

Remedium Lifecare Ltd.

BSE: 539561 SECTOR: Trading  68k   128   11

1.09
0 0
BSE: 13 Jun 04:01 PM

Price Summary

Today's High

₹ 1.18

Today's Low

₹ 1.09

52 Week High

₹ 15.13

52 Week Low

₹ 1.09

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

96.14 Cr.

Enterprise Value

152.32 Cr.

No. of Shares

88.2 Cr.

P/E

63.01

P/B

1.05

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  1.03

CASH

1.52 Cr.

DEBT

57.7 Cr.

Promoter Holding

1.11 %

EPS (TTM)

₹  0.02

Sales Growth

692.75%

ROE

122.76 %

ROCE

99.51%

Profit Growth

503.2 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year692.75%
3 Year255.4%
5 Year660.29%

Profit Growth

1 Year503.2%
3 Year308.4%
5 Year427.68%

ROE%

1 Year122.76%
3 Year72.73%
5 Year48.03%

ROCE %

1 Year99.51%
3 Year73.4%
5 Year47.75%

Debt/Equity

1.3432

Price to Cash Flow

-1.3

Interest Cover Ratio

11.5476

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 1.11 0.00
Dec 2024 1.11 0.00
Sep 2024 1.11 0.00
Jun 2024 1.11 0.00
Mar 2024 1.11 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 255.397255683973% for the Past 3 years.
  • Company has been maintaining healthy ROE of 72.7296% over the past 3 years.
  • Company has been maintaining healthy ROCE of 73.3995333333333% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 11.5476.
  • The company has an efficient Cash Conversion Cycle of 19.3708 days.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 116.416474165369.

 Limitations

  • Company has negative cash flow from operations of -74.1611.
  • The company has a low EBITDA margin of 3.36658% over the past 5 years.
  • The company is trading at a high EV/EBITDA of 137.4893.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 1408.49 77.7 25.08 38.15 81.57
Total Expenditure 1443.52 77.31 20.62 43.63 82.75
Operating Profit -35.03 0.39 4.46 -5.48 -1.18
Other Income 2.89 1.89 0.82 7.43 0.66
Interest 3.85 0 2.81 0.88 1.59
Depreciation 0.01 0.01 0.01 0.01 0.01
Exceptional Items 0 0 0 0 0
Profit Before Tax -36 2.27 2.46 1.06 -2.12
Tax 17.72 0.63 0.68 0.3 0.52
Profit After Tax -53.72 1.64 1.78 0.76 -2.64
Adjusted EPS (Rs) -0.93 0.03 0.03 0.01 -0.05

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 2.89 90.03 504.79 509.84 4041.71
Total Expenditure 2.5 89.31 502.98 502.67 4007.51
Operating Profit 0.39 0.72 1.82 7.17 34.19
Other Income 0.01 0.01 0.01 0.83 21.1
Interest 0.01 0.02 0.23 0.45 4.78
Depreciation 0.01 0.06 0.07 0.15 0.06
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.38 0.65 1.53 7.4 50.45
Tax 0.1 0.17 0.45 1.97 17.72
Net Profit 0.28 0.48 1.08 5.43 32.73
Adjusted EPS (Rs.) 0 0.01 0.02 0.09 0.57

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 3.6 3.6 3.6 3.6 10.08
Total Reserves -0.25 0.26 1.34 6.76 32.88
Borrowings 0.36 10.5 0 0 0
Other N/C liabilities 0 0 0 -0.01 -0.03
Current liabilities 0.55 24.17 218.82 1143.86 1904.97
Total Liabilities 4.27 38.53 223.76 1154.22 1947.9
Assets
Net Block 0.23 0.21 0.19 0.08 0.05
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0 0 0 0 0
Other N/C Assets 0 0 0 0 0
Current Assets 4.04 38.32 223.57 1154.14 1947.85
Total Assets 4.27 38.53 223.76 1154.22 1947.9
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 0.38 0.65 1.53 7.4 50.45
Adjustment 0.01 0.06 0.18 0.19 3.84
Changes in Assets & Liabilities -0.59 -10.89 10.03 14.89 -110.64
Tax Paid 0 -0.04 -0.45 -1.98 -17.81
Operating Cash Flow -0.2 -10.21 11.28 20.5 -74.16
Investing Cash Flow -0.24 -0.04 -0.05 -0.04 0.09
Financing Cash Flow 0.29 10.14 -10.61 -0.04 53.74
Net Cash Flow -0.15 -0.11 0.62 20.42 -20.33

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 1.11 1.11 1.11 1.11 1.11
siddharth chimanlal shah 1.11 1.11 1.11 1.11 1.11
PARTICULARS Jun 2023% Sep 2023% Dec 2023% Mar 2024% Jun 2024%
investors 98.89 98.89 98.89 98.89 98.89
alok ashok tiwari 1.73 1.59 1.59 1.59 1.46
amit prakash masalia 1.89 1.89 1.89 1.89 1.89
chirag narendra modh 4.20 4.20 4.20 4.20 4.20
cnm finvest private limit... 5.45 5.45 5.45 4.59 4.59
deena prakash masalia 1.81 1.81 1.81 1.81 1.81
dhansukhbhai champaklal j... 2.64 2.64 2.64 2.64 2.64
jayashree d singh 1.60 1.60 1.60 1.60 1.60
jiteshkumar shashikantbha... 2.78 2.78 2.78 2.78 2.78
jyotika shenoy - - - - 2.06
kamlesh pravinchandra sha... 2.45 2.29 2.14 1.39 1.27
lalit kumar lalwani . 1.79 1.79 - - 1.16
maryam maqbool dhoki 1.94 1.94 1.94 1.94 1.12
mukesh kumar naresh 1.62 1.62 1.62 1.62 1.62
padmavathy kaimal kondath... 1.46 1.46 1.46 1.59 1.59
payal amit masalia 1.78 1.78 1.78 1.78 1.78
remedium escrow suspense ... - 4.39 - - 3.05
sadhana santhosh shanbhag... 1.11 1.11 - 1.06 1.06
sathish srinivas nayak - - - - 2.72
sheela rajendrakumar kaim... - - - 1.69 1.69
sudhakar jha 1.60 - - 1.60 1.55
uppinangady sudhindra nay... 8.10 7.94 - 7.47 6.99
vasanth kumar bantwal 1.67 1.67 1.67 1.55 1.55
venkatesh bhaskar shenoy 3.98 3.99 3.99 3.23 2.19
vignesh . 5.69 - - - 5.92
vishek . masalia 2.95 2.95 - 2.95 2.95
achintya securities priva... - - - 1.53 -
guruprasad sitaram kudva 1.46 1.46 1.46 1.19 -
jyotika deepak shenoy 6.54 5.55 5.26 3.19 -
kamlesh pravinchandra sha... 1.33 1.29 - 1.09 -
lalit kumar lalwani - - 1.79 1.63 -
radhika vasanth 1.14 1.14 - 1.04 -
sathish s nayak 3.78 3.78 3.78 3.42 -
tulsi arvindakshan nair - - 1.47 1.18 -
vignesh - - 5.69 5.94 -
achinya securities privat... - - 1.31 - -
kamlesh pravinchandra - - 1.24 - -
kapil mahesh kothari 1.40 1.40 1.00 - -
minal uday doshi 1.09 1.08 1.07 - -
radhika vasanth - - 1.14 - -
sadhana santhosh - - 1.11 - -
sheela rajendra kaimal 1.47 1.47 1.47 - -
uppinangady sudhindra - - 7.76 - -
vishek masalia - - 2.95 - -
tulasi arvindakshan nair 1.47 1.47 - - -
vignesh . - 5.69 - - -
heroic mercantile 1.15 - - - -

Annual Reports

Title Action
Annual Report 2021
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY ACTION
No Credit reports exist for this company.Report us
TYPE AGENCY ACTION
No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER ACTION
Currently we do not have any Concall related to this company.Report us
TYPE QUARTER ACTION
Currently we do not have any Presentation related to this company.Report us

Company News

 No Latest News available for this company.
Report us

Remedium Lifecare Stock Price Analysis and Quick Research Report. Is Remedium Lifecare an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Remedium Lifecare stock price today is Rs 1.09. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Remedium Lifecare . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Remedium Lifecare has a PE ratio of 63.0057803468208 which is high and comparatively overvalued .

  • Share Price: - The current share price of Remedium Lifecare is Rs 1.09. One can use valuation calculators of ticker to know if Remedium Lifecare share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Remedium Lifecare has ROA of 2.1102 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Remedium Lifecare has a Current ratio of 1.0225 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Remedium Lifecare has a ROE of 122.7641 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Remedium Lifecare has a Debt to Equity ratio of 1.3432 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Remedium Lifecare has reported revenue growth of 692.7455 % which is fair in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Remedium Lifecare for the current financial year is 0.84601388814284 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Remedium Lifecare is Rs 0 and the yield is 0 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Remedium Lifecare is Rs 0.0173 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Remedium Lifecare in Ticker for free. Also, one can get the intrinsic value of Remedium Lifecare by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Remedium Lifecare
X